Model-Driven Scale-Up from High-Throughput to Bench-Top Scale
Carmen Jungo Rhême, Anna Kress, Angela Botros
Abstract
Bioprocess development for microbial systems typically requires extensive experimentation across multiple scales, from high-throughput miniaturized systems to lab-scale bioreactors. This study presents a hybrid modeling framework that integrates data from miniaturized high-throughput microbioreactor experiments (BioLector XT, ~800 µL) and 5 L lab-scale fed-batch cultivations of Escherichia coli ATCC 25922GFP for the expression of GFP under IPTG induction.
A model-based design of experiments (MBDoE) approach was employed to systematically vary key process parameters, induction time, inducer (IPTG) concentration, feed rate, and temperature, generating 96 screening runs across 24 conditions and 10 large-scale runs across 6 conditions. The hybrid model, combining mechanistic mass balances with Gaussian process machine learning for the specific growth and production rates, was trained using a bootstrap aggregation strategy to improve robustness and quantify prediction uncertainty. Cross-scale normalization was applied to reconcile sensor differences between scales prior to joint modeling. The resulting model achieved test set relative RMSE values of approximately 0.19–0.20 for both biomass and GFP, comparable to the intrinsic biological replicate variability.
A systematic transfer learning and run-to-run optimization analysis further demonstrated that models informed by small-scale data require as few as one large-scale calibration run to achieve strong predictive accuracy at scale. These results highlight the potential of hybrid modeling to substantially reduce the number of costly large-scale experiments required during bioprocess development and scale-up.

Carmen Jungo Rhême
Director Biofactory Competence Center and Full Professor
Carmen Jungo studied chemical engineering at EPFL, where she also obtained a PhD in bioprocess engineering in 2007. She has 17 years of industrial experience with a proven track record in leading biopharmaceutical companies manufacturing therapeutic recombinant proteins, including Lonza, Merck Serono, UCB Farchim and CSL Behring.
Her expertise spans bioprocess development, scale up, technology transfer, and the start up of large scale recombinant manufacturing facilities. She also brings extensive experience in people and project management, including capital investment projects. Since November 2023, she is Full Professor of Bioprocess Engineering at HEIA FR and Head of the Biofactory Competence Center.

Anna Kress
Manager Application Science
Anna Kress is an trained biotechnologist with over 10 years of experience in the Life Science Industry. She holds a Bachelor and a Master of Science in Molecular Biotechnology. In 2015 she joined the R&D department in the company m2p labs as a Scientist. In the following years Anna had different roles in R&D and led a team of scientists in the development of microbioreactors. Following the acquisition of m2p-labs by Beckman Coulter Life Sciences
Anna took on Technical Product Management responsibilities and since beginning of 2023 built an Applications team for the Biotech Business unit.
.png?width=1485&height=1898&name=Speakers%20Headshots%2026%20(4).png)
Angela Botros
Senior Process Modeling Scientist
Angela is a Senior Process Modelling Scientist and Product Owner at DataHow. She is working with various customers, focusing mainly on upstream microbial projects and is responsible for the planning and development of new features in DataHowLab. Angela holds a BSc and MSc in electrical engineering from ETH Zurich and a PhD in biomedical engineering from University of Bern.
